Glioblastoma and other primary brain malignancies in adults: a review

LR Schaff, IK Mellinghoff - Jama, 2023 - jamanetwork.com
Importance Malignant primary brain tumors cause more than 15 000 deaths per year in the
United States. The annual incidence of primary malignant brain tumors is approximately 7 …

Isocitrate dehydrogenase (IDH) mutant gliomas: a Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

JJ Miller, LN Gonzalez Castro, S McBrayer… - Neuro …, 2023 - academic.oup.com
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …

An independently validated survival nomogram for lower-grade glioma

H Gittleman, AE Sloan, JS Barnholtz-Sloan - Neuro-oncology, 2020 - academic.oup.com
Background Gliomas are the most common primary malignant brain tumor. Diffuse low-
grade and intermediate-grade gliomas, which together compose the lower-grade gliomas …

Role of the microenvironment in glioma pathogenesis

MA Jayaram, JJ Phillips - Annual Review of Pathology …, 2024 - annualreviews.org
Gliomas are a diverse group of primary central nervous system tumors that affect both
children and adults. Recent studies have revealed a dynamic cross talk that occurs between …

Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review

M IJzerman-Korevaar, TJ Snijders, A de Graeff… - Journal of neuro …, 2018 - Springer
Background Glioma patients suffer from a wide range of symptoms which influence quality of
life negatively. The aim of this review is to give an overview of symptoms most prevalent in …

Postoperative risk of IDH-mutant glioma–associated seizures and their potential management with IDH-mutant inhibitors

MR Drumm, W Wang, TK Sears… - The Journal of …, 2023 - Am Soc Clin Investig
Seizures are a frequent complication of adult-type diffuse gliomas, and are often difficult to
control with medications. Gliomas with mutations in isocitrate dehydrogenase 1 or 2 …

New insights into molecules and pathways of cancer metabolism and therapeutic implications

Z Tang, Z Xu, X Zhu, J Zhang - Cancer Communications, 2021 - Wiley Online Library
Cancer cells are abnormal cells that can reproduce and regenerate rapidly. They are
characterized by unlimited proliferation, transformation and migration, and can destroy …

Establishment of age group classification for risk stratification in glioma patients

Z Lin, R Yang, K Li, G Yi, Z Li, J Guo, Z Zhang… - BMC neurology, 2020 - Springer
Background Age is associated with the prognosis of glioma patients, but there is no uniform
standard of age-group classification to evaluate the prognosis of glioma patients. In this …

IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation

A Mortazavi, I Fayed, M Bachani, T Dowdy… - Neuro …, 2022 - academic.oup.com
Background Uncontrolled seizures in patients with gliomas have a significant impact on
quality of life and morbidity, yet the mechanisms through which these tumors cause seizures …

Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) …

D Schiff, M Van den Bent, MA Vogelbaum… - Neuro …, 2019 - academic.oup.com
The finding that most grades II and III gliomas harbor isocitrate dehydrogenase (IDH)
mutations conveying a relatively favorable and fairly similar prognosis in both tumor grades …